{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:43:34Z","timestamp":1776602614692,"version":"3.51.2"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Electrophoresis tests are reported as negative, positive, or\u2014rarely\u2014as suspicious for monoclonal band (SfMB). This study aimed to determine the fate of patients with SfMB findings in long-term follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with SfMB results obtained in 2019 were retrospectively identified. These patients were examined for the presence of any control electrophoresis test until their most recent hospital visit in 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2019, electrophoresis tests were reported for a total of 1289 patients. In total, 115 patients with no prior electrophoresis test results were reported as positive (newly diagnosed patients) and 30 patients with no prior electrophoresis test results were reported as SfMB. Among the 30 SfMB cases, control electrophoresis tests had yielded a positive result in 2 patients and a negative result in 12 patients. In the remaining 16 patients, 7 were without control electrophoresis test results but had long clinical follow-up, whereas 9 were without a control electrophoresis test result and clinical follow-up. In 357 patients with a previously diagnosed monoclonal gammopathy, 18 were reported as SfMG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>None of the patients initially reported as having an SfMB developed monoclonal gammopathy during their follow-up period. We recommend that cases reported as \u201csuspicious\u201d be managed separately in patients with and without a prior monoclonal gammopathy diagnosis, where the term \u201cweak positive\u201d may be more appropriate in patients with a known monoclonal gammopathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/labmed\/lmag013","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:42:10Z","timestamp":1772109730000},"source":"Crossref","is-referenced-by-count":0,"title":["Suspicious bands in serum and urine protein immunofixation electrophoresis tests in patients with and without a history of monoclonal gammopathies: a retrospective database study"],"prefix":"10.1093","volume":"57","author":[{"given":"Merve","family":"Dincer","sequence":"first","affiliation":[{"name":"Biochemistry Laboratory, Antalya Education and Research Hospital , Antalya, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6123-6186","authenticated-orcid":false,"given":"Ozgur","family":"Aydin","sequence":"additional","affiliation":[{"name":"Biochemistry Laboratory, Antalya Education and Research Hospital , Antalya, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volkan","family":"Karakus","sequence":"additional","affiliation":[{"name":"Hematology Clinic, Antalya Education and Research Hospital , Antalya, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guzin","family":"Aykal","sequence":"additional","affiliation":[{"name":"Biochemistry Laboratory, Antalya Education and Research Hospital , Antalya, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"key":"2026041908075705800_lmag013-B1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working Group","year":"2003","journal-title":"British J Haematol"},{"key":"2026041908075705800_lmag013-B2","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/clinchem\/46.8.1230","article-title":"Understanding and identifying monoclonal gammopathies","volume":"46","author":"Attaelmannan","year":"2000","journal-title":"Clin Chem"},{"key":"2026041908075705800_lmag013-B3","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"2026041908075705800_lmag013-B4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"2026041908075705800_lmag013-B5","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1016\/j.clml.2020.01.017","article-title":"Consensus guidelines on the diagnosis of multiple myeloma and related disorders: recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium","volume":"20","author":"Bergstrom","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2026041908075705800_lmag013-B6","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1097\/HS9.0000000000000528","article-title":"Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment, and follow-up","volume":"5","author":"Dimopoulos","year":"2021","journal-title":"Hemasphere"},{"key":"2026041908075705800_lmag013-B7","first-page":"340","article-title":"Mono- and oligoclonal immunoglobulin anomalies in kidney transplant patients","volume":"34","author":"Cakalaroski","year":"2000","journal-title":"Ann Utol (Paris)"},{"key":"2026041908075705800_lmag013-B8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1309\/AJCPT6OWWMHITA1Y","article-title":"Laboratory persistence and clinical progression of small monoclonal abnormalities","volume":"138","author":"Murray","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"2026041908075705800_lmag013-B9","doi-asserted-by":"crossref","DOI":"10.1201\/b13302","volume-title":"Protein Electrophoresis in Clinical Diagnosis","author":"Keren","year":"2003"},{"key":"2026041908075705800_lmag013-B10","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1515\/cclm-2015-0580","article-title":"Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias","volume":"54","author":"Willrich","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"2026041908075705800_lmag013-B11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.hoc.2024.03.003","article-title":"Early detection of precursor diseases of multiple myeloma","volume":"38","author":"O\u2019Donnell","year":"2024","journal-title":"Hematol Oncol Clin"},{"key":"2026041908075705800_lmag013-B12","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/jalm\/jfaa153","article-title":"Serum and urine protein electrophoresis and serum-free light chain assays in the diagnosis and monitoring of monoclonal gammopathies","volume":"5","author":"Singh","year":"2020","journal-title":"J Appl Lab Med"},{"key":"2026041908075705800_lmag013-B13","first-page":"105","article-title":"Understanding and interpreting serum protein electrophoresis","volume":"71","author":"O\u2019Connell","year":"2005","journal-title":"Am Fam Physician"},{"key":"2026041908075705800_lmag013-B14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.14744\/ijmb.2025.84748","article-title":"Unnecessary serum protein electrophoresis test requests in the follow-up of multiple myeloma patients can be prevented","volume":"8","author":"Ayd\u0131n","year":"2025","journal-title":"Int J Med Biochem"}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/57\/3\/lmag013\/68111439\/lmag013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/57\/3\/lmag013\/68111439\/lmag013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:08:06Z","timestamp":1776600486000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/doi\/10.1093\/labmed\/lmag013\/8658844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmag013","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,3]]},"article-number":"lmag013"}}